For patients undergoing percutaneous coronary intervention (PCI), tailoring antiplatelet therapy based on the results of platelet function testing makes no difference in the risk of recurrent ischemic ...
In patients undergoing percutaneous coronary intervention (PCI), intensifying antiplatelet therapy based on platelet reactivity testing reduces cardiovascular mortality and stent thrombosis, according ...
November 10, 2011 (San Francisco, California)— Investigators who explored platelet-function testing for guiding antiplatelet therapy in a low-risk PCI population, who earlier this year had announced ...
Use of platelet function testing during dual antiplatelet therapy, including a P2Y12 antagonist, in acute coronary syndromes does not improve clinical outcomes. Researchers at King's College London ...
Aortic-valve stenosis can be complicated by bleeding that is associated with acquired type 2A von Willebrand syndrome. However, the prevalence and cause of the hemostatic abnormality in aortic ...
Different types of coagulation tests, such as PT, APTT, ACT, etc., are carried out for assessing blood clotting function in patients. Most of the hematology analyzers are capable of providing ...
Today at the American Association of Clinical Chemistry (AACC) Annual Meeting in Chicago, Illinois, Dade Behring Inc. (NASDAQ:DADE) introduced the BCS(R) XP System, the newest addition to the ...
A new study successfully identifies new genetic variants involved in the formation of platelets and more importantly, defines how genes near these variants affect platelet size and number using a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback